Your browser doesn't support javascript.
loading
The multi-kinase inhibitor afatinib serves as a novel candidate for the treatment of human uveal melanoma.
Shu, Wenying; Zhu, Xue; Wang, Ke; Cherepanoff, Svetlana; Conway, R Max; Madigan, Michele C; Zhu, Hong; Zhu, Ling; Murray, Michael; Zhou, Fanfan.
Afiliação
  • Shu W; Department of Pharmacy, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, 511400, Guangdong Province, China.
  • Zhu X; Key Laboratory of Nuclear Medicine, Ministry of Health, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi, 214063, Jiangsu Province, China.
  • Wang K; Key Laboratory of Nuclear Medicine, Ministry of Health, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi, 214063, Jiangsu Province, China.
  • Cherepanoff S; SydPath, Department of Anatomical Pathology, St Vincent's Hospital, Darlinghurst, NSW, 2010, Australia.
  • Conway RM; Ocular Oncology Unit, Sydney Eye Hospital and The Kinghorn Cancer Centre, Sydney, NSW, 2006, Australia.
  • Madigan MC; Save Sight Institute, The University of Sydney, Sydney, NSW, 2006, Australia.
  • Zhu H; Save Sight Institute, The University of Sydney, Sydney, NSW, 2006, Australia.
  • Zhu L; School of Optometry and Vision Sciences, University of New South Wales, Sydney, NSW, 2006, Australia.
  • Murray M; Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, Zhejiang Province, China.
  • Zhou F; Save Sight Institute, The University of Sydney, Sydney, NSW, 2006, Australia.
Cell Oncol (Dordr) ; 45(4): 601-619, 2022 Aug.
Article em En | MEDLINE | ID: mdl-35781872

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Uveais / Antineoplásicos Limite: Animals / Humans Idioma: En Revista: Cell Oncol (Dordr) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Uveais / Antineoplásicos Limite: Animals / Humans Idioma: En Revista: Cell Oncol (Dordr) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China